FindTrial
Sign In

Novel Strategies for Precision Classification and Stratified Therapeutics in Sepsis Based on Multidimensional Data: Analysis of Inflammatory Regulation in Sepsis and Development of a Precision Immune Subtyping System

Novel Strategies for Precision Classification and Stratified Therapeutics in Sepsis Based on Multidimensional Data: Analysis of Inflammatory Regulation in Sepsis and Development of a Precision Immune Subtyping System

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113317
Enrollment
Unknown
Registered
2025-11-27
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis/Sepsis shock

Interventions

Observation group:None

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Meets the Sepsis-3 diagnostic criteria for sepsis or septic shock; 2.Signed informed consent form obtained from the patient or their legally authorized representative; 3.Age between 18 and 89 years, inclusive.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Severe life-threatening comorbidities (e.g., terminal-stage malignancies, hematologic disorders, being bedridden due to cerebrovascular disease, dementia, or renal failure requiring long-term hemodialysis); 3.Any patient whom the investigator judges unlikely to complete the trial.

Design outcomes

Primary

MeasureTime frame
Inflammatory Cytokine Expression Profile;—

Countries

China

Contacts

Public ContactSong Zhenju

Zhongshan Hospital, Fudan University

song.zhenju@zs-hospital.sh.cn+86 21 64041990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026